Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Malignant transformation of fibroblasts and epithelial cells is often accompanied by increased hyaluronan production and accumulation. Despite recent progress in the study of hyaluronan biosynthesis, the mechanisms underlying the transformation-induced overproduction of hyaluronan have not been elucidated. Here we report that activity and transcriptional levels of hyaluronan synthase (HAS) significantly increased after oncogenic malignant transformation of a rat 3Y1 fibroblast cell line. Of three HAS isoforms (HAS1, HAS2, and HAS3), only HAS2 gene expression was increased in the v-Ha-ras transformed 3Y1 cells, which show less malignancy. In contrast, both HAS1 and HAS2 expressions were elevated in the highly malignant cells transformed with v-src and/or v-fos. To assess the contribution of HAS expression to the oncogenic malignant transformation, we established stable cell transfectants expressing sense and antisense HAS genes. Antisense suppression of the HAS2 expression significantly decreased hyaluronan production in the cells transformed by the oncogenic v-Ha-ras and eventually led to a reduction in tumorigenicity in the rat peritoneum. The introduction of the HAS1 and HAS2 genes promoted the growth of subcutaneous tumors in a manner dependent on the levels of hyaluronan synthesis. Significant growth promotion was observed within a wide range of HAS1 expression. In contrast, the growth stimulation was only seen within a narrow range of HAS2 expression, and high levels of HAS2 expression even inhibited tumor growth. These results suggest that proper regulation of the expression of each HAS isoform is required for optimal malignant transformation and tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25085 · Cited by 901
Self-citation
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
“A recent study confirmed that reducing HAS levels using antisense techniques suppresses tumour growth, but showed that extremely high hyaluronan levels also inhibit tumour growt”
BackgroundHyaluronan fragments: An information-rich system
Stern, R., Asari, A. A., & Sugahara, K. N. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.05.009 · Cited by 1,132
Hyaluronan in Tissue Injury and Repair
Jiang, D., Liang, J., & Noble, P. W. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123337 · Cited by 835
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Hyaluronan in human malignancies
Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P. K., Anttila, M., & Kosma, V.-M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294
Role, Metabolism, Chemical Modifications and Applications of Hyaluronan
Volpi, N., Schiller, J., Stern, R., & Soltes, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186138 · Cited by 282
A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone
Kakizaki, I., Kojima, K., Takagaki, K., Endo, M., Kannagi, R., Ito, M., Maruo, Y., Sato, H., Yasuda, T., Mita, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405918200 · Cited by 277
Self-citationChoi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
Therapeutic value of glycosaminoglycans in cancer
Yip, G. W., Smollich, M., & Götte, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0082 · Cited by 263
Sebastian, A., Hum, N. R., Martin, K. A., Gilmore, S. F., Peran, I., Byers, S. W., Wheeler, E. K., Coleman, M. A., & Loots, G. G. (2020) · Cancers · doi:10.3390/cancers12051307 · Cited by 260
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.026 · Cited by 223
Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00001-0 · Cited by 204
“…by HA synthases HAS1, HAS2, and HAS3, which are integral plasma membrane enzymes with an intracellular active site that catalyzes alternating monosaccharide addition to an average mass of 100–2,000 kDa (Itano et al., 1999), concurrent with extrusion of the polymer to the exterior of the cell.”
Proteoglycans and their roles in brain cancer
Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C., James, C. D., & Phillips, J. J. (2013) · The FEBS Journal · doi:10.1111/febs.12109 · Cited by 193
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J., & Schroeder, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0863 · Cited by 178
A novel role of low molecular weight hyaluronan in breast cancer metastasis
Wu, M., Cao, M., He, Y., Liu, Y., Yang, C., Du, Y., Wang, W., & Gao, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-259978 · Cited by 163
“Differences in the expression pattern of HA synthase isoforms were reported to correlate with the aggressive phenotype of cancer cells (36, 37).”
BackgroundLi, Y., Li, L., Brown, T. J., & Heldin, P. (2007) · International Journal of Cancer · doi:10.1002/ijc.22550 · Cited by 158
“Several studies have implicated HAS2 expression in the promotion of tumor cell growth, both in vitro and in vivo.(14,32,35,36) On the basis of our finding that the aggressive Hs578T cells, which synthesize the highest amounts of hyaluronan among the 5 studied human breast cancer cell lines, predominantly expressed HAS…”
BackgroundRegulation of Colonic Epithelial Repair in Mice by Toll-Like Receptors and Hyaluronic Acid
Zheng, L., Riehl, T. E., & Stenson, W. F. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.055 · Cited by 118
Metadata
- Authors
- Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., & Kimata, K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18679-18687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2131272801
- Cited by
- 138
- References
- 1
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.